-
Something wrong with this record ?
High frequency of point mutations in the nitroreductase 4 and 6 genes of Trichomonas vaginalis associated with metronidazole resistance
I. Iturrieta-Gonzalez, P. Olivares-Ferretti, A. Hidalgo, F. Zambrano, X. Ossa, F. Fonseca-Salamanca, A. Melo
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 1966
ProQuest Central
from 2004-01-01 to 3 months ago
Health & Medicine (ProQuest)
from 2004-01-01 to 3 months ago
Public Health Database (ProQuest)
from 2004-01-01 to 3 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1982
PubMed
39584737
DOI
10.14411/fp.2024.021
Knihovny.cz E-resources
- MeSH
- Antiprotozoal Agents pharmacology MeSH
- Point Mutation * MeSH
- Drug Resistance * MeSH
- Humans MeSH
- Metronidazole * pharmacology MeSH
- Nitroreductases * genetics metabolism MeSH
- Protozoan Proteins genetics metabolism MeSH
- Trichomonas Vaginitis parasitology MeSH
- Trichomonas vaginalis * genetics drug effects enzymology MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Chile MeSH
Trichomoniasis, a globally distributed sexually transmitted infection, is caused by the urogenital parasite Trichomonas vaginalis Donné, 1836 affecting both women and men. The treatment of choice is metronidazole (MTZ). In the present study, 15 samples of vaginal discharge and urine were analysed by sequencing nitroreductase genes (ntr4 and ntr6). An in silico model was structured to illustrate the location of point mutations (PM) in the protein. The ntr4 gene presented four PMs: G76C (10/10), C213G (9/10), C318A (5/10) and G424A (1/10), while the ntr6 gene had eight PMs; G593A (13/13) the most frequent, G72T and G627C, both in 8/13. The PM C213G and A438T generated a stop codon causing a truncated nitroreductase 4 and 6 protein. Docking analysis demonstrated that some models had a decrease in binding affinity to MTZ (p < 0.0001). A high frequency of mutations was observed in the samples analysed that could be associated with resistance to MTZ in Chile.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25000301
- 003
- CZ-PrNML
- 005
- 20250110092627.0
- 007
- ta
- 008
- 250107e20241107xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14411/fp.2024.021 $2 doi
- 035 __
- $a (PubMed)39584737
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Iturrieta-Gonzalez, Isabel $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $u Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera. Temuco, Chile $1 https://orcid.org/0000000184269530
- 245 10
- $a High frequency of point mutations in the nitroreductase 4 and 6 genes of Trichomonas vaginalis associated with metronidazole resistance / $c I. Iturrieta-Gonzalez, P. Olivares-Ferretti, A. Hidalgo, F. Zambrano, X. Ossa, F. Fonseca-Salamanca, A. Melo
- 520 9_
- $a Trichomoniasis, a globally distributed sexually transmitted infection, is caused by the urogenital parasite Trichomonas vaginalis Donné, 1836 affecting both women and men. The treatment of choice is metronidazole (MTZ). In the present study, 15 samples of vaginal discharge and urine were analysed by sequencing nitroreductase genes (ntr4 and ntr6). An in silico model was structured to illustrate the location of point mutations (PM) in the protein. The ntr4 gene presented four PMs: G76C (10/10), C213G (9/10), C318A (5/10) and G424A (1/10), while the ntr6 gene had eight PMs; G593A (13/13) the most frequent, G72T and G627C, both in 8/13. The PM C213G and A438T generated a stop codon causing a truncated nitroreductase 4 and 6 protein. Docking analysis demonstrated that some models had a decrease in binding affinity to MTZ (p < 0.0001). A high frequency of mutations was observed in the samples analysed that could be associated with resistance to MTZ in Chile.
- 650 12
- $a Trichomonas vaginalis $x genetika $x účinky léků $x enzymologie $7 D014246
- 650 12
- $a nitroreduktasy $x genetika $x metabolismus $7 D009601
- 650 12
- $a metronidazol $x farmakologie $7 D008795
- 650 12
- $a bodová mutace $7 D017354
- 650 12
- $a léková rezistence $7 D004351
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a protozoální proteiny $x genetika $x metabolismus $7 D015800
- 650 _2
- $a antiprotozoální látky $x farmakologie $7 D000981
- 650 _2
- $a trichomonádová vaginitida $x parazitologie $7 D014247
- 651 _2
- $a Chile $7 D002677
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Olivares-Ferretti, Pamela $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $1 https://orcid.org/0000000157593271
- 700 1_
- $a Hidalgo, Alejandro $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $u Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera. Temuco, Chile $1 https://orcid.org/0000000222474878
- 700 1_
- $a Zambrano, Fabiola $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $u Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera. Temuco, Chile $1 https://orcid.org/0000000348400508
- 700 1_
- $a Ossa, Ximena $u Public Health Department, Centre of Excellence Training, Research and Management for Evidence-Based Health (CIGES), Universidad de La Frontera, Temuco, Chile $1 https://orcid.org/0000000326260946
- 700 1_
- $a Fonseca-Salamanca, Flery $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $u Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera. Temuco, Chile $1 https://orcid.org/0000000311713105
- 700 1_
- $a Melo, Angelica $u Centre of Excellence in Translational Medicine, Nucleus of Scientific and Technological Bioresources (CEMT-BIOREN), Faculty of Medicine. Universidad de La Frontera, Temuco, Chile $u Department of Pathological Anatomy, Faculty of Medicine. Universidad de La Frontera. Temuco, Chile *Address for correspondence: Angelica Melo Angermeyer. Universidad de La Frontera, Faculty of Medicine, Edificio Biociencias, Av. Alemania 0458 Temuco, Chile. E-mail: angelica.melo@ufrontera.cl; ORCID-iD: 0000-0002-3576-1745 $1 https://orcid.org/0000000277033578
- 773 0_
- $w MED00011006 $t Folia parasitologica $x 1803-6465 $g Roč. 71 (20241107)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39584737 $y Pubmed
- 910 __
- $a ABA008 $b online $c $y - $z 0
- 990 __
- $a 20250107 $b ABA008
- 991 __
- $a 20250110092620 $b ABA008
- 999 __
- $a kom $b bmc $g 2247186 $s 1236301
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 71 $c - $e 20241107 $i 1803-6465 $m Folia parasitologica $n Folia Parasitol (Praha) $x MED00011006
- LZP __
- $a Pubmed-20250107